Items where Author is "Freemantle, N."
Article
Moncrieff, J., Crellin, N., Stansfeld, J. , Cooper, R., Marston, L., Freemantle, N., Lewis, G., Hunter, R., Johnson, S., Barnes, T., Morant, N., Pinfold, V., Smith, R., Kent, L., Darton, K., Long, M. 
ORCID: 0000-0002-6920-9676, Horowitz, M., Horne, R., Vickerstaff, V., Jha, M. & Priebe, S. (2023).
Antipsychotic dose reduction and discontinuation versus maintenance treatment in people with schizophrenia and other recurrent psychotic disorders in England (the RADAR trial): an open, parallel-group, randomised controlled trial.
The Lancet Psychiatry, 10(11),
pp. 848-859.
doi: 10.1016/s2215-0366(23)00258-4
Crellin, N. E., Priebe, S., Morant, N. , Lewis, G., Freemantle, N., Johnson, S., Horne, R., Pinfold, V., Kent, L., Smith, R., Darton, K., Cooper, R. E., Long, M. ORCID: 0000-0002-6920-9676, Thompson, J., Gruenwald, L., Freudenthal, R., Stansfeld, J. L. & Moncrieff, J. (2022).
An analysis of views about supported reduction or discontinuation of antipsychotic treatment among people with schizophrenia and other psychotic disorders.
BMC Psychiatry, 22(1),
article number 185.
doi: 10.1186/s12888-022-03822-5
Saunders, L. J., Zhu, H., Bunce, C. V. , Doré, C. J., Freemantle, N., Crabb, D. P. & Ophthalmic Statistics Group, . (2015). Ophthalmic statistics note 5: diagnostic tests-sensitivity and specificity. British Journal of Ophthalmology, 99(9), pp. 1168-1170. doi: 10.1136/bjophthalmol-2014-306055